Drug Evaluation Committee Survey to understand the needs of healthcare professionals regarding drug safety information (physicians and pharmacists) - Preliminary report - (conducted in May 2023)
Pharmacovigilance Subcommittee
December 2023
Under the VISION of "contributing to patient safety and security by establishing an ideal system for providing safety information from the viewpoints of patients and healthcare professionals and delivering necessary information," we are working to promote risk communication using DX. Although there is an impression that the medium for providing information from pharmaceutical companies to medical care providers has been changing amid environmental changes, the actual situation with safety information has not been clear. Therefore, in May 2023, we conducted a questionnaire survey of healthcare professionals to understand the current situation and issues, and compiled the results in a preliminary report.
Deliverables of the Drug Evaluation Committee Return to list of all deliverables